MARK G. OSTERMAN

** ****** **** 610-***-****

Berwyn, PA 19312 ad2vup@r.postjobfree.com

Summary

Global Life Science Commercial Executive

Business Development Experience with Transaction Background/Deal Sheet

Extensive Biotech/Pharmaceutical Experience across Multiple Therapeutic Areas

Six Sigma Greenbelt and Executive Leadership Training

Big Brothers, Hospice, Knights of Columbus Volunteer Activity

Professional Experience

Kineticos LLC, Raleigh, North Carolina 2015

Operating Executive

Created BioPharma practice and expanded client base by 200%. Worked with clients in startup phase to large multinational clients including Biotech/Pharma/Device/Diagnostic

Created business development strategy, commercial strategy, reimbursement analysis and BD

Lead valuation and product analysis for multiple early-stage biotech companies including Locus Bioscience and Brammer Bio

Advised and implemented business development strategy for company with COVID therapy under EUA

DoseCue/OSG, Philadelphia, Pa 2008-2015

Founder

Created business strategy, financial model, and launch plan for medication compliance start up.

Coordinated initial funding for angel investment and business development strategy

Provide commercial and business development strategy for startup biotech and large pharmaceutical companies

SOLSTICE NEUROSCIENCES, INC., Malvern, PA 2007-2008

Vice President, Global Marketing

Recruited to establish turnaround marketing strategy for MYOBLOC. Established new marketing, reimbursement, business development, and corporate communication plan. Managed international partners through launch of brand in EU, Japan, and Korea. Managed 65-person commercial organization

Restructured existing marketing, reimbursement, and communication groups. Provided interim leadership for sales organization

Launched new marketing campaign and trained sales organization

Led business development for out/in licensing initiatives

Created new reimbursement strategy for transition of in-house operations and field-based organization

DISCOVERY LABS, INC., Doylestown, PA 2004-2006

Senior Vice President, Commercial Operations

Recruited by CEO to established internal commercial organization and terminated contractual commercial obligations. Directed company through transition from R&D to a commercial organization. Recruited and managed 24-person commercial organization

Created a new sales, marketing, and distribution organization in eight months. Identified and recruited top organizational talent for entry into Neonatal/Inhalation Technology market.

Successfully led commercial organization through challenging environment. (regulatory, cultural, financial)

Negotiated new partnership agreements and restructured/terminated current agreements.

JOHNSON & JOHNSON, New Brunswick, NJ 2003-2004

Vice President, Stem Cell Internal Venture

Recruited by former Centocor CEO to create new internal and external investment strategy within the venture capital division of J&J. Managed 23-person internal venture

Raised significant financing to align the J&J stem cell strategy both internally and externally to reduce parallel investments

Established Internal Venture division within Johnson & Johnson for long-term innovation and entrepreneurial leadership.

Launched new venture and created business unit to support cellular therapy for cardiovascular disease.

Led commercial due diligence for the acquisition of Scios ($2.44 billion) within a two month period.

Recognized as high potential candidate and offered extensive management and leadership training based upon consistently exceeding corporate performance metrics.

CENTOCOR, INC., Malvern, PA 2001-2003

Executive Director, Cardio-Pulmonary, Metabolic Products, Autoimmune and Mimetibody Portfolio-Global Biologics Strategic Marketing Group

Championed the cardiovascular, pulmonary, autoimmune, metabolism, and infectious disease therapeutic areas. Launched the pulmonary and metabolism therapeutic areas for Centocor. Involved in numerous business development projects related to areas of responsibility. Launched the business unit for the MIMETIBODY™ platform with responsibility for building business plan. Managed 11-person department

GSK., Philadelphia, PA 1988-2001

Global Director, Pulmonary Portfolio-Global Marketing Group

Coordinated and executed the international strategic launch plan for Ariflo that included marketing,

sales, regulatory, clinical, public relations, pricing, health economics, and life cycle management.

GLAXO WELLCOME, INC., Raleigh, NC

Product Manager, Serevent Marketing

Developed marketing launch plan for two new indications, COPD and Pediatrics. Developed market

overview, market strategy, position and message. Created strategy and tactics for success in the approximately $2.7 billion Asthma/COPD market.

Pulmonary Research Liaison, Baltimore, MD

Established long term relationships and partnerships with internationally recognized thought leaders/researchers, including biotechnology companies like Kimeragen, Molecular Tool; research institutions: John Hopkins, National Institutes of Health, Georgetown University, University of Virginia

.

Education

B.A., Economics, North Carolina State University, Raleigh, NC 1988

B.A., Business Management, North Carolina State University, Raleigh, NC 1988

Executive Education Course, Finance for Senior Executives, Harvard Business School 2002

Publication

Journal of Medical Economics, Economic and Clinical Impact of a Novel, Light-based, at-Home Antiviral Treatment on Mild-to-Moderate COVID-19 Emerson D. et al

Contact this candidate